Loading stock data…
IDEXX Laboratories (IDXX)
$535.93-15.57 (-2.82%)
After Hours$537.61+1.68 (+0.31%)· Last close Jun 29
IDEXX Laboratories, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
IDEXX Laboratories, Inc. in the Healthcare sector is trading at $535.93 with a market capitalization of $45.2B. Wall Street consensus targets $709.14 (14 analysts), implying a +32.3% move over the next 12 months. The stock is currently near its 52-week low of $506.91, remaining 14.9% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +32.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.14B↑ | $1.09B↓ | $1.11B↓ | $1.11B↑ | $998.43M |
| Gross Profit | $722.74M↑ | $658.11M↓ | $683.35M↓ | $694.73M↑ | $623.38M |
| Operating Income | $362.59M↑ | $315.61M↓ | $354.85M↓ | $373.05M↑ | $316.53M |
| Net Income | $278.45M↑ | $248.19M↓ | $274.61M↓ | $293.99M↑ | $242.68M |
Peer Comparison
JNJUNHPFE
Fundamentals
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Co...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$45.16B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
70.38%
Volume
Today's trading volume
799,311
Recent News
Is the Options Market Predicting a Spike in IDEXX Laboratories Stock?
Investors need to pay close attention to IDXX stock based on the movements in the options market lately.
A Small Upgrade Could Have a Big Impact for IDEXX Customers
With a short percentage of shares outstanding of 2.76%, IDEXX Laboratories, Inc. (NASDAQ:IDXX) is among the 7 Best Pet Care Stocks to Buy for Consistent Recurring Revenue. On May 26, IDEXX Laboratories, Inc. (NASDAQ:IDXX) announced the expansion of its Fecal Dx antigen testing platform to include detection of taeniid tapeworm species, including Taenia and Echinococcus. The enhanced testing capability is […]
Is IDEXX Laboratories Stock Underperforming the Nasdaq?
IDEXX Laboratories has trailed the Nasdaq Composite over the past year, and analysts are fairly bullish on its future growth potential.
Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IDEXX Parasite Test Expansion Links Zoonotic Risk And Valuation Debate
IDEXX Laboratories (NasdaqGS:IDXX) has expanded its Fecal Dx antigen testing to detect taeniid tapeworm in companion animals. The broadened panel includes medically significant Echinococcus species, a key zoonotic parasite of concern for veterinarians and public health officials. The update targets regions where taeniid tapeworm and Echinococcus are a growing focus for disease surveillance and prevention. IDEXX Laboratories, a veterinary diagnostics and software company, continues to build...